How does emerging patent case law in the US and Europe affect precision medicine?: How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

Mateo Aboy; Glenn  Cohen; Kathleen Liddell; Johnathan Liddicoat; Cristina Crespo; Sara Gerke; Timo Minssen

doi:10.1038/s41587-019-0265-1

How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

Mateo Aboy, Glenn Cohen, Kathleen Liddell, Johnathan Liddicoat, Cristina Crespo, Sara Gerke, Timo Minssen

4 Citations (Scopus)

Abstract

Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future of
precision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

Original language	English
Journal	Nature Biotechnology
Volume	37
Issue number	10
Pages (from-to)	1118–1125
Number of pages	8
ISSN	1087-0156
DOIs	https://doi.org/10.1038/s41587-019-0265-1
Publication status	Published - 2 Oct 2019

Keywords

Faculty of Law
pecision medicine
patents
Biomarkers
diagnostics
Artificial intelligence
big data
algorithm engineering

Access to Document

10.1038/s41587-019-0265-1

Fingerprint

Dive into the research topics of 'How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?'. Together they form a unique fingerprint.

Cite this

Aboy, M., Cohen, G., Liddell, K., Liddicoat, J., Crespo, C., Gerke, S., & Minssen, T. (2019). How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? Nature Biotechnology, 37(10), 1118–1125. https://doi.org/10.1038/s41587-019-0265-1

How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? / Aboy, Mateo; Cohen, Glenn ; Liddell, Kathleen et al.
In: Nature Biotechnology, Vol. 37, No. 10, 02.10.2019, p. 1118–1125.

Research output: Contribution to journal › Journal article › Research › peer-review

Aboy, M, Cohen, G, Liddell, K, Liddicoat, J, Crespo, C, Gerke, S & Minssen, T 2019, 'How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?', Nature Biotechnology, vol. 37, no. 10, pp. 1118–1125. https://doi.org/10.1038/s41587-019-0265-1

Aboy M, Cohen G, Liddell K, Liddicoat J, Crespo C, Gerke S et al. How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? Nature Biotechnology. 2019 Oct 2;37(10):1118–1125. doi: 10.1038/s41587-019-0265-1

@article{e380d499b22e4851a81b9573f6fdda05,

title = "How does emerging patent case law in the US and Europe affect precision medicine?: How will today{\textquoteright}s patent law affect tomorrow{\textquoteright}s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?",

abstract = "Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today{\textquoteright}s law will affect tomorrow{\textquoteright}s innovation.",

keywords = "Faculty of Law, pecision medicine, patents, Biomarkers, diagnostics, Artificial intelligence, big data, algorithm engineering",

author = "Mateo Aboy and Glenn Cohen and Kathleen Liddell and Johnathan Liddicoat and Cristina Crespo and Sara Gerke and Timo Minssen",

year = "2019",

month = oct,

day = "2",

doi = "10.1038/s41587-019-0265-1",

language = "English",

volume = "37",

pages = "1118–1125",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "nature publishing group",

number = "10",

}

TY - JOUR

T1 - How does emerging patent case law in the US and Europe affect precision medicine?

T2 - How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?

AU - Aboy, Mateo

AU - Cohen, Glenn

AU - Liddell, Kathleen

AU - Liddicoat, Johnathan

AU - Crespo, Cristina

AU - Gerke, Sara

AU - Minssen, Timo

PY - 2019/10/2

Y1 - 2019/10/2

N2 - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

AB - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.

KW - Faculty of Law

KW - pecision medicine

KW - patents

KW - Biomarkers

KW - diagnostics

KW - Artificial intelligence

KW - big data

KW - algorithm engineering

UR - https://rdcu.be/bSLBa

UR - https://www.nature.com/articles/s41587-019-0265-1

U2 - 10.1038/s41587-019-0265-1

DO - 10.1038/s41587-019-0265-1

M3 - Journal article

C2 - 31578504

SN - 1087-0156

VL - 37

SP - 1118

EP - 1125

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 10